Evaluation of Interventions for Sleep Disturbances in PASC

What is the Purpose of this Study?

The purpose of this study is to determine whether certain interventions can help treat sleep disturbances that started or worsened following a COVID infection and have lasted for at least 12 weeks. Sleep disturbances include excessive drowsiness, problems falling and staying asleep, and problems with sleep-wake patterns. These disturbances are known to be associated with post-acute sequelae of SARS-CoV-2 infection (PASC) or Long COVID. This study will examine the effects that the interventions may have on the ability to recover from sleep disturbances associated with Long COVID. Participants will be adults who experience sleep disturbances as a symptom of Long COVID and who have not had another COVID infection in the last 4 weeks. They will also be screened and assigned to a sub-study that best matches the type of sleep disturbance they are experiencing. Each sub-study contains 1 or more active study intervention group and an inactive study intervention group. An intervention could include a study drug, a study device, a behavioral approach, or a combination of these interventions.


Eligibility


Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

RECOVER-SLEEP A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in PASC

Study Details
Disease Type/Condition

Other

Principal Investigator

Chen, Peter

Age Group

Adult

Phase

II

IRB Number

STUDY00003446

ClinicalTrials.gov ID

NCT06404099

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Chen, Peter

Age Group

Adult

Phase

II

IRB Number

RECOVER-SLEEP

ClinicalTrials.gov ID

NCT06404099

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org